EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Timing of intravenous immunoglobulin treatment and outcome in Guillain – Barré syndrome: Is time nerve?

Young Gi Min iD, Yoon-Ho Hong, Yusuf A Rajabally, Jung-Joon Sung iD

Muscle & Nerve · 2024

DOI: 10.1002/mus.28271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2024. Verfasst von Young Gi Min und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome, Immunoglobulins, Intravenous. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Despite treatment, a considerable proportion of patients with Guillain–Barré syndrome (GBS) experience poor recovery, highlighting a therapeutic need. There is a lack of evidence that treatment timing affects recovery. This study aims to investigate the effects of intravenous immunoglobulin (IVIg) timing on disability and speed of recovery in GBS.

Methods

We performed a retrospective study of 136 IVIg‐treated GBS patients admitted to two Korean centers between 2010 and 2021. We analyzed the effect of time to IVIg on the GBS disability scale (GBS‐DS) and the degree of improvement from nadir (∆GBS‐DS) at 1, 3, 6, and 12 months, as well as the time to regain the ability to walk or run unaided. Time to IVIg was treated either as a continuous variable or categorized into 1‐week intervals to explore critical time windows. Known prognostic factors, the modified Erasmus GBS Outcome Scores on admission and pre‐treatment serum albumin levels were adjusted as covariates.

Results

Shorter time to IVIg was independently associated with better GBS‐DS, greater ∆GBS‐DS, and shorter time to walk or run unaided at all time points. The therapeutic effect of IVIg was notably diminished when administered beyond the first 2 weeks of onset.

Discussion

Our study highlights the timing of IVIg as a modifiable prognostic factor in GBS. The earlier IVIg is initiated, the better the outcomes, with the ideal time window being within the first 2 weeks. These findings underscore the importance of prompt diagnosis and early intervention to optimize recovery in GBS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guillain-Barre SyndromeImmunoglobulins, IntravenousHumansMaleFemaleMiddle AgedRetrospective StudiesAdultTreatment OutcomeAgedTime FactorsImmunologic FactorsRecovery of FunctionTime-to-Treatment

Stichwörter der Autor:innen

Guillain–Barré syndromeclinical practiceimmunotherapyintravenous immunoglobulintreatment timing

Substanzen

Immunoglobulins, IntravenousImmunologic Factors

Autor:innen und Institutionen

  • Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Neurology, Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea.
  • Aston Medical School, School of Health and Life Sciences, Birmingham, UK.
  • Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Neuroscience Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Young Gi Min, Jung-Joon Sung

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Min, Y. G., Hong, Y. H., Rajabally, Y. A., & Sung, J. J. (2024). Timing of intravenous immunoglobulin treatment and outcome in Guillain – Barré syndrome: Is time nerve?. Muscle & Nerve. https://doi.org/10.1002/mus.28271

Vancouver

Min YG, Hong YH, Rajabally YA, Sung JJ. Timing of intravenous immunoglobulin treatment and outcome in Guillain – Barré syndrome: Is time nerve?. Muscle & Nerve. 2024. doi:10.1002/mus.28271

BibTeX
@article{Min2024,
  author = {Min, Young Gi and Hong, Yoon-Ho and Rajabally, Yusuf A and Sung, Jung-Joon},
  title = {Timing of intravenous immunoglobulin treatment and outcome in Guillain – Barré syndrome: Is time nerve?},
  journal = {Muscle & Nerve},
  year = {2024},
  doi = {10.1002/mus.28271}
}
Kostenlos starten →